Trials / Unknown
UnknownNCT04360733
Precision Immunology to Determine the Immune Response in Patients With COVID-19
Precision Immunology Approach to Better Understand the Divergent Host Responses Towards Infection With SARS-CoV-2
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University of Bonn · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To better understand the immune response to SARS-CoV-2 infection, we devised a precision immunology approach to systematically study the immune function of different patient cohorts
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood draw | serial blood draw and subsequent deep immune phenotyping analysis, (ii.) immune activation assays, (iii.) transcriptome and (iv.) epigenome analysis in an overarching (v.) bioinformatics data analysis |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2022-04-01
- Completion
- 2022-09-01
- First posted
- 2020-04-24
- Last updated
- 2021-05-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04360733. Inclusion in this directory is not an endorsement.